Navigation Links
Ferring Initial Purchase Order and Guaranteed Letter of Credit Launches Five Year Contract
Date:3/28/2008

ment and commercialization of potential products, protection of the Company's intellectual property, and economic conditions generally. Additional information on potential factors that could affect results and other risks and uncertainties are detailed from time to time in the Company's periodic reports, including Forms 10-KSB, 10-QSB, 8-K, and other forms filed with the Securities and Exchange Commission ("SEC"). These statements have not been evaluated by the Food and Drug Administration. Resurgex(R), Resurgex Plus(R), Resurgex Select(R) and Surgex(TM) are not intended to diagnose, treat, cure, or prevent and disease.


'/>"/>
SOURCE Millennium Biotechnologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Millennium Biotechnologies, Inc. Signs Marketing and Distribution Agreement with Ferring Pharmaceuticals
2. Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award
3. Smart Medical Technology, Inc. Awarded Novation Contract for Ground-breaking Liftaem(TM) System that Aids Lifting and Transferring Patients
4. Kiwa Bio-Tech New Bio-Fertilizer Product Granted Initial Fertilizer Registration Certificate By Ministry of Agriculture of the PRC
5. Environmental Operating Solutions Completes Initial Tranche of $2.5 Million Institutional Financing
6. BrainCells Inc. Completes $30 Million Initial Closing of Series B Financing
7. Omeros Corporation Files Registration Statement for Proposed Initial Public Offering
8. Pharmos Corporation Completes Initial Closing of Private Placement
9. Reliant Pharmaceuticals Announces the Filing of Registration Statement on Form S-1 For an Initial Public Offering
10. Vasogen and Grupo Ferrer Announce Initial Roll-out of Celacade - New Therapy for Chronic Heart Failure
11. Nventa completes enrollment and initial dosing of second cohort in Phase 1 HspE7 safety trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... 2015 PRC Clinical, a ... at the ACRP 2015 Global Conference and Exhibition on ... Association of Clinical Research Professionals (ACRP) Global Conference and ... focused on the conduct of clinical trials. ACRP supports ... widely recognized industry certifications. , The ACRP 2015 ...
(Date:4/21/2015)... 2015 A leading manufacturer of stainless ... to discuss its custom fabrication services today at INTERPHEX ... which launched just prior to the INTERPHEX event. The ... 22 and 23) at the Javits Center in New ... world’s largest and most innovative pharmaceutical and biotech firms ...
(Date:4/20/2015)... MENLO PARK, Calif. , April 20, ... DMPI) (DelMar and the Company), a biopharmaceutical company ... in new orphan drug indications, today announced promising ... of the American Association for Cancer Research ... lead product candidate VAL-083 (dianhydrogalactitol) to ...
(Date:4/20/2015)... FOSTER CITY, Calif. , April 20, 2015 /PRNewswire/ ... with InterpretOmics Pvt. Ltd. to provide an integrated Big ... analysis of all biomarkers collected in the context of ... the needs of precise or multi-targeted drug candidates, stratified ... efficacy and disease progression free survival. ...
Breaking Biology Technology:PRC Clinical Sponsors The ACRP 2015 Global Conference And Meets Biotech Companies in the Salt Lake City Area. 2HOLLOWAY AMERICA to Reveal Newly Designed Responsive Website at INTERPHEX 2015 Today 2HOLLOWAY AMERICA to Reveal Newly Designed Responsive Website at INTERPHEX 2015 Today 3DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 2DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 3DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 4DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 5PointCross Life Sciences and InterpretOmics partner for Clinical and Genomic Biomarker Management for Drug Development 2
... VIPs, New Platform to Reach Wide Investor Audience, ... and,microprocessor technologies for use in portable monitoring devices,announced today ... using WallStreet VIPs, new platform on April 29, 2008 ... April 10 "SPO Medical is a company,on the ...
... DIEGO, April 10 MedImmune today announced that,researchers ... programs at the Annual Meeting of the American ... to,excellence in oncology research., "Cancer research has ... MedImmune and we,are proud to share data from ...
... Science Foundation,(NSF) has awarded Loma Linda University a ... lead a consortium in developing an,innovative model for ... Taylor, Ph.D., Professor of Microbiology,and Molecular Genetics, and ... project with Rohit Shukla, CEO and founder of ...
Cached Biology Technology:SPO Medical to Conduct Live Investor Meeting on April 29, 2008 2SPO Medical to Conduct Live Investor Meeting on April 29, 2008 3MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research 2MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research 3Loma Linda University Partners With Larta Institute for Technology Marketing Program 2
(Date:4/13/2015)... , April 13, 2015 ... Research, "Global Biometrics Market Forecast & Opportunities, 2020", the ... CAGR of around 14% till 2020. The biometrics ... large scale implementation and review of biometric management ... of new products with greater efficiency, are resulting ...
(Date:4/8/2015)... , April 8, 2015  Infinisource, a leading ... services, and Morpho, a leading supplier of biometric ... produce the market,s most advanced biometrically-enabled time clock, ... NXG time clock is setting a bold, new ... data for the small and mid-size employer. When ...
(Date:4/2/2015)... Sweden , April 2, 2015 ... for Q1 2015 attributed to somewhat higher than 125 ... in the year-end report 2014 that revenues for Q1 ... that the company reported for Q4 2014. The operating ... to be negative. The complete interim report will as ...
Breaking Biology News(10 mins):Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3Fingerprint Cards Revises Revenues for Q1 2015 2
... The age-old maxim "Eat breakfast like a king, lunch like ... be the best advice to follow to prevent metabolic syndrome, ... study. Metabolic syndrome is characterized by abdominal obesity, ... The study, published online March 30 in the International ...
... . . A new pulsed magnet ... Source shatters previous field strength limits for pulsed neutron ... to develop the new technique, which uses a 30-Tesla ... high magnetic fields. ,Neutron scattering analysis at these high ...
... One of the most common house ant species might have ... in a forest, but the ants have found ways to ... Buczkowski, a Purdue University research assistant professor of entomology, found ... as they move from forest to city and act somewhat ...
Cached Biology News:Bacon or bagels? Higher fat at breakfast may be healthier than you think, says UAB research 2Story tips from the US Department of Energy's Oak Ridge National Laboratory April 2010 2Common house ants form supercolonies, prosper in urban settings 2
... ABsolute QPCR SYBR Green Mixes are optimised for ... components necessary to perform Quantitative PCR, with the ... SYBR Green Mix contains optimal levels of active ... supplied in a proprietary reaction buffer that enables ...
Rabbit polyclonal to Vitronectin ( Abpromise for all tested applications). Antigen: Full length Vitronectin protein (Mouse). Entrez Gene ID: 7448 Swiss Protein ID: P04004...
... Assay Kits are ideal for studying or ... GR Competitor Assay Kits contain partially purified ... of the following proprietary fluorescent glucocorticoid Fluormone ... (red assay kit), or GS Far Red ...
McCoy's 5A Medium. Without Tryptose or Phosphate Broth. Contains Sodium Bicarbonate....
Biology Products: